“`html
Paternal Valproate Use Linked to Increased Risk of Neurodevelopmental Disorders, Study Finds
Table of Contents
A new study published November 10, 2025, in JAMA Network Open suggests a potential link between a father’s use of the epilepsy drug valproate and an increased risk of neurodevelopmental disorders (NDD) in their children. While experts caution that more research is needed, the findings add to a growing body of evidence examining the impact of paternal medication exposure on offspring advancement.
Conflicting Research Fuels Debate
Valproate, a widely prescribed medication for epilepsy and bipolar disorder, has long been known to pose risks to fetal development when taken by pregnant women.However, the potential effects of valproate use by fathers have been less clear, with previous studies yielding inconsistent results.One retrospective study involving 90,000 men, published in Nature Communications in 2025, found no association between paternal valproate use and NDD. This contrasts sharply with the current research, which indicates a potential increased risk.
Researchers analyzed data from over 5,000 families in Scandinavia, examining the prevalence of NDD in children whose fathers had taken valproate or other epilepsy medications. The analysis revealed that 4-5% of children born to fathers taking valproate exhibited NDD, compared to 2-3% of children whose fathers were taking other epilepsy drugs.After adjusting for other contributing factors, the study estimated the risk of NDD from valproate to be approximately 50% higher than with other epilepsy medications, though the excess risk could be as low as 9% due to inherent study limitations.
Causation Remains Unproven
Despite the observed association, experts emphasize that observational studies cannot definitively prove causation. “Observational studies are unable enough to prove that valproate causes NDD,” one leading reproductive endocrinologist stated. Designing clinical trials to directly assess this link is ethically challenging,as intentionally exposing a developing fetus to a possibly harmful drug is unacceptable. However, the fact that epilepsy medications act on the brain lends biological plausibility to the potential connection with NDD.
Other Risk Factors must Be Considered
It’s important to note that other established risk factors for NDD, such as older paternal age and certain occupational exposures, also play a role. these factors must be considered alongside potential medication effects.
Expert Perspectives: Caution and Continued Monitoring
Experts urge caution in interpreting the findings and advise against drastic changes in medication regimens.”I really don’t think we know if valproate causes NDD, but there are potential risks,” saeid a senior official at Imperial College London. “It is premature to suggest that couples should avoid pregnancy while the male partner is on valproate.”
Another expert, a professor of andrology at the University of Manchester, echoed this sentiment, stating that the results are “not sufficiently robust for all men of reproductive age to be switched from Valproate to another type of medication.” However, he added that men with concerns should discuss the findings with their doctors.
Men currently taking valproate are strongly advised not to discontinue the medication without consulting their physician, as doing so could be dangerous. Instead, thay should engage in open interaction with their healthcare provider to explore potential alternative treatments if they have concerns about reproductive health.
The study, ‘Paternal Valproate Use and Neurodevelopmental Disorder and Congenital Malformation Risk in Offspring’ by Sandrine Colas et al.,was published in JAMA Network Open on November 10,2025 (DOI: 10.1001/jamanetworkopen.2025.42581). Further research is crucial to fully understand the potential risks associated with paternal valproate exposure and to provide informed guidance to couples planning families.
Did you know? – A study links paternal valproate use to a possible increased risk of neurodevelopmental disorders in children. The research, published in JAMA Network Open, analyzed data from over 5,000 families in Scandinavia.
Pro tip: – Men taking valproate should not stop the medication without consulting their doctor. Discuss any concerns about reproductive health with a healthcare provider to explore potential alternative treatments.
Reader question: – Does this study prove valproate causes NDD? No, observational studies cannot definitively prove causation. Experts
